Optimasi dan Evaluasi Mikrokapsul Ibuprofen Tersalut Lilin Lebah

Abstract

Ibuprofen is a non-steroid anti-inflammatory drug for treating rheumatoid arthritis. It has a short biological half-life and can impose gastrointestinal irritation, so that a controlled drug release system is required, one of which is by microencapsulation technique. In this research, microencapsulation of ibuprofen was done by emulsion-solvent evaporation method. Variation of ibuprofen:beeswax ratio (1:1, 1:2, and 1:3) and concentration of gelatine emulsifier (1, 1.5, 2, and 2.5%) were tested to obtain optimum microcapsule. The yield of microencapsulation were varied from 77.17 to 88.84%. The highest encapsulation efficiency of ibuprofen was 93.78%, obtained in microcapsule with beeswax-ibuprofen ratio 1:1 and gelatine concentration 2%. Variation concentration of gelatine significantly influenced the encapsulation efficiency at ratio 1:3. Microcapsule with the highest encapsulation efficiency released 38.22% of ibuprofen in gastric fluid simulation medium for 6 hours. The kinetics of ibuprofen release followed Korsmeyer-Peppas model. The microcapsule particles size ranged from 200 to 250 μm. Based of these results, it was concluded that microencapsulation of ibuprofen with beeswax can maintain the release rate of drug in intestine.